Prurisol: Efficacy seems to be dose-related in Pha
Post# of 72440
(Total Views: 512)
Posted On: 05/16/2017 8:05:35 PM
Prurisol: Efficacy seems to be dose-related in Phase 2a.
In the ITT population where >= 2-point improvement in IGA was observed at week 12, 25% was in the 200 mg arm, 10.7% was in the 100 mg arm, 10.3% was in the 50 mg arm.
In the PP population where >= 2-point improvement in IGA was observed at week 12, 35% was in the 200 mg arm, 13% was in the 100 mg arm, 15% was in the 50 mg arm.
Dosage in Phase 2b will increase to 300 mg and 400 mg, so efficacy should improve.
In the ITT population where >= 2-point improvement in IGA was observed at week 12, 25% was in the 200 mg arm, 10.7% was in the 100 mg arm, 10.3% was in the 50 mg arm.
In the PP population where >= 2-point improvement in IGA was observed at week 12, 35% was in the 200 mg arm, 13% was in the 100 mg arm, 15% was in the 50 mg arm.
Dosage in Phase 2b will increase to 300 mg and 400 mg, so efficacy should improve.
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼